Special Issue "Marine Drug Development and Pre-clinical Studies for Infection and Inflammation"
Deadline for manuscript submissions: 31 December 2024 | Viewed by 101
Interests: drug discovery; bioassay development; algal toxins and natural products; immunology; inflammation modulation
Special Issues, Collections and Topics in MDPI journals
Natural and synthetic derivatives of marine natural products represent a largely unmet supply for drug discovery for a variety of health conditions affecting humans and marine life. The marine environment has been a veritable source for anti-infective agents (such as antibiotics) to combat pathogens. Increasingly, studies have also shown that marine natural products and derivatives are useful to attenuate inflammation and other immune disorders. Early identification, isolation, and characterization of these marine compounds can have the potential to not only impact human and marine health but also teach us lessons about the marine species itself and the process of drug discovery involving organisms of marine origin.
Due to the unique marine environment, some drug discovery efforts may be hindered by components found in the compound of interest that enhance or detract from bioassay development. Likewise, some inherent properties of compounds from marine species may enhance the power of drug discovery through the development of new bioassay tools.
For this Special Issue, we invite academic and industry scientists to submit reviews and original and conceptual research articles that highlight the biological activities of known or novel marine compounds and their role in early drug discovery, particularly for applications to infection and immunity.
Dr. Jennifer McCall
Dr. Laurie A. Minns
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- bioassay guided drug discovery
- infectious disease
- anti-viral immune modulation
- autoimmune disease
- marine natural products